MDNA Life Sciences Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:MDNA Life Sciences Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10382
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MDNA Life Sciences Inc (MDNA) is a molecular diagnostics company that develops molecular tests based on the mitochondrial genome. The company’s prostate core mitomic test is based on the science of mitochondrial DNA, a tissue-based prostate cancer diagnostics for prostate and other cancers. Its target therapy areas include prostate cancer, pancreatic cancer, lung cancer, ovarian cancer and endometriosis. The company’s tests are used for biomarker discovery, early disease detection, monitoring, risk assessment and therapeutic targeting. It serves patients, medical providers and manufacturers of skin and sun care products. MDNA is headquartered in West Palm Beach, Florida, the US.

MDNA Life Sciences Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MDNA Life Sciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
MDNA Life Sciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
MDNA Life Sciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
MDNA Life Sciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
MDNA Life Sciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
MDNA Life Sciences Inc, Medical Equipment, Deal Details 10
Asset Purchase 10
MDNA Life Sciences Acquires Mitomic Technology from Mitomics 10
Venture Financing 11
MDNA Life Sciences Raises USD0.2 Million in Venture Financing 11
MDNA Life Sciences Raises USD0.4 Million in Venture Financing 12
MDNA Life Sciences Raises USD0.1 Million in Venture Financing 13
Partnerships 14
LabCorp Enters into Licensing Agreement with MDNA Life Sciences 14
Phi Life Sciences Enters into Licensing Agreement with MDNA Life Sciences 15
Helomics Partners with MDNA Life Sciences 16
MDNA Life Sciences Inc – Key Competitors 17
MDNA Life Sciences Inc – Key Employees 18
MDNA Life Sciences Inc – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Product News 20
Apr 06, 2018: MDNA Life Sciences Strengthens its Global Patent Portfolio with Multiple Granted Patents 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
MDNA Life Sciences Inc, Medical Equipment, Key Facts 2
MDNA Life Sciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
MDNA Life Sciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
MDNA Life Sciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
MDNA Life Sciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
MDNA Life Sciences Inc, Deals By Market, 2012 to YTD 2018 8
MDNA Life Sciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
MDNA Life Sciences Acquires Mitomic Technology from Mitomics 10
MDNA Life Sciences Raises USD0.2 Million in Venture Financing 11
MDNA Life Sciences Raises USD0.4 Million in Venture Financing 12
MDNA Life Sciences Raises USD0.1 Million in Venture Financing 13
LabCorp Enters into Licensing Agreement with MDNA Life Sciences 14
Phi Life Sciences Enters into Licensing Agreement with MDNA Life Sciences 15
Helomics Partners with MDNA Life Sciences 16
MDNA Life Sciences Inc, Key Competitors 17
MDNA Life Sciences Inc, Key Employees 18

List of Figures
MDNA Life Sciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
MDNA Life Sciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
MDNA Life Sciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
MDNA Life Sciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
MDNA Life Sciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
MDNA Life Sciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
MDNA Life Sciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
MDNA Life Sciences Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[MDNA Life Sciences Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Grupo Grana y Montero SAA (GRAMONC1):企業の財務・戦略的SWOT分析
    Grupo Grana y Montero SAA (GRAMONC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Shree Renuka Sugars Ltd (RENUKA):企業の財務・戦略的SWOT分析
    Shree Renuka Sugars Ltd (RENUKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Australia and New Zealand Banking Group Ltd:企業の戦略・SWOT・財務情報
    Australia and New Zealand Banking Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Australia and New Zealand Banking Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Amerisur Resources Plc (AMER):石油・ガス:M&Aディール及び事業提携情報
    Summary Amerisur Resources Plc (Amerisur) is an independent full cycle oil and gas company. It focuses on the exploration, development and production of oil and natural gas in onshore South America, primarily in Colombia and Paraguay. Amerisur has working interests in the Platanillo - OBA cluster, P …
  • Kellogg Co:企業の戦略・SWOT・財務情報
    Kellogg Co - Strategy, SWOT and Corporate Finance Report Summary Kellogg Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • VIA Technologies, Inc (2388):企業の財務・戦略的SWOT分析
    VIA Technologies, Inc (2388) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Themis Bioscience GmbH (THISR):製薬・医療:M&Aディール及び事業提携情報
    Summary Themis Bioscience GmbH (Themis Bioscience) is a biotechnology company that develops prophylactic vaccines for emerging tropical infections. The company develops emerging and specialist indications and vaccines from preclinical to late-stage clinical development phases. It develops novel vacc …
  • Semma Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Semma Therapeutics Inc (Semma Therapeutics) is a biotechnology company that develops cell replacement therapy for the treatment of diabetes. The company develops therapies using stem cells of the individuals with Type 1 diabetes to produce their own insulin that will regulate the blood sugar …
  • Trinidad Drilling Ltd (TDG):企業の財務・戦略的SWOT分析
    Summary Trinidad Drilling Ltd (Trinidad Drilling) is an oil and gas company that offers drilling services. The company’s services include land and barge drilling, coring and presetting, well servicing, rig design and management, rig fleet management, and technical support services. Its in-house manu …
  • Dance Biopharm Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Dance Biopharm Inc (Dance Biopharm), a subsidiary of Dance Biopharm Holdings Inc, formerly Dance Pharmaceuticals Inc, is a biotechnology company that develops inhaled insulin products to treat diabetes patients. The company provides product pipeline such as Dance-501, a pocket-sized inhaler …
  • Takeda Pharmaceuticals USA Inc-製薬・医療分野:企業M&A・提携分析
    Summary Takeda Pharmaceuticals USA Inc (TPUSA), formerly Takeda Pharmaceuticals North America Inc, a subsidiary of Takeda Pharmaceutical Company Ltd, is a developer, manufacturer and distributor of pharmaceutical drugs. The company’s products include pioglitazone and glimepiride, lubiprostone, piogl …
  • CEZ Group:電力:M&Aディール及び事業提携情報
    Summary CEZ Group (CEZ), a subsidiary of CEZ AS, is an integrated electricity conglomerate company. The company produces and markets electricity. It generates, trades, and distributes power and heat. CEZ also provides coal mining services. The company offers services such as telecommunications, info …
  • Oscotec Inc (039200):企業の財務・戦略的SWOT分析
    Summary Oscotec Inc (Oscotec) is a biotechnology company which discovers and develops drugs for cancer treatments. The company’s pipeline products include SKI-O-703, a spleen tyrosine kinase (SYK) inhibitor, against rheumatoid arthritis and idiopathic thrombocytopenic purpura; lazertinib (GNS-1480 Y …
  • Vivus Inc (VVUS):製薬・医療:M&Aディール及び事業提携情報
    Summary Vivus Inc (Vivus) is a biopharmaceutical company which develops and commercializes next-generation therapeutics for addressing unmet needs in obesity, sleep apnea, diabetes and sexual health. The company's marketed products include, Qsymia (phentermine and topiramate extended-release), indic …
  • Hayashibara Co Ltd:企業の戦略的SWOT分析
    Hayashibara Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Greer Laboratories Inc-製薬・医療分野:企業M&A・提携分析
    Summary Greer Laboratories Inc (Greer), a subsidiary of Stallergenes Greer plc, is a pharmaceutical company that provides allergy immunotherapy products and services to the healthcare industry. The company provides products in the area of human allergy, veterinary allergy and source materials. It of …
  • Autobio Diagnostics Co Ltd-医療機器分野:企業M&A・提携分析
    Summary Autobio Diagnostics Co Ltd (Autobio) is a clinical diagnostic company that offers research and development; production and distribution of clinical diagnostic products. The company’s products include immunoassays, mycoplasma, blood culture bottle, bacterial vaginosis, microplate luminometer, …
  • Huge China Holdings Limited (428):企業の財務・戦略的SWOT分析
    Huge China Holdings Limited (428) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Alkaloid AD Skopje (ALK):企業の財務・戦略的SWOT分析
    Summary Alkaloid AD Skopje (Alkaloid Skopje) is a pharmaceutical company that manufactures cosmetic, pharmaceuticals, botanicals and chemical products. The company’s cosmetic products include skin care products, soaps, hair care products, perfumes and household cleaners. It offers chemical products, …
  • NanoString Technologies Inc (NSTG):医療機器:M&Aディール及び事業提携情報
    Summary NanoString Technologies Inc (NanoString) is a developer of life science tools for translational research and molecular diagnostics. The company's products include sprint profiler, Dx analysis system with flex, nCounter MAX analysis system, protein assays, solid tumor assays, gene fusion pane …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆